Skip to main content
Home

Search form

  • ABOUT US
    • ECFS Society Details
      • Society Information
      • Applications for Support
    • ECFS Membership
      • Membership Subscription
      • Membership Demographics
    • Other Information
      • Latest News
      • Job Opportunities
      • Grants and Programmes
      • Links
  • RESEARCH
    • ECFS Projects
      • ECFS Clinical Trials Network
      • ECFS Patient Registry
    • ECFS Working Groups
      • Diagnostic Network
      • Exercise
      • Neonatal Screening
      • Fungal Pathogens
      • Pulmonary Exacerbation
    • Special Projects
      • ECFS / CF Europe Post-Doctoral Research Fellowship
      • CFQ-R questionnaire and CF candidates for lung transplant
      • EU funded projects
      • MucoFong International Project
      • Complete CFTR gene mutation analysis in European patients with Cystic Fibrosis
    • Past Working Groups
      • Cystic Fibrosis Molecular and Cell Biology and Physiology Basic Science
      • ECFS Gene Modifier Working Group
      • ECFS Non Tuberculous Mycobacteria Working Group
  • CARE
    • ECFS Standards Of Care
    • ECFS Working Groups
      • Exercise
      • Diagnostic Network
      • Neonatal Screening
      • Mental Health
      • Fungal Pathogens
      • Pulmonary Exacerbation
      • Telehealth
    • Allied Health Professionals
      • ECFS Nursing Special interest Group
      • European CF Pharmacy Group
      • European Cystic Fibrosis Nutrition Group
      • European Psychosocial Special Interest Group
      • ECFS Physiotherapy Special Interest International Group
  • EDUCATION
  • CONFERENCES & EVENTS
    • European Cystic Fibrosis Conference
    • ECFS Basic Science Conference
    • Related events
    • Past ECFS conferences
  • PUBLICATIONS
    • About Publications
      • The Journal of Cystic Fibrosis
      • ECFS Newsletter
      • ECFS Book
      • ERS Monograph
    • Resources
      • Search All Resources
      • CF Research News
      • Consensus Reports
      • ECFS Guidelines
      • Free Access Articles
      • CF Literature
  • MEMBERSHIP
  • LOG IN

Other Guidelines

Strategies for newborn screening for cystic fibrosis: A systematic review of health economic evaluations.

  • Read more about Strategies for newborn screening for cystic fibrosis: A systematic review of health economic evaluations.

Prevalence of hypoglycemia during oral glucose tolerance testing in adults with cystic fibrosis and risk of developing cystic fibrosis-related diabetes.

  • Read more about Prevalence of hypoglycemia during oral glucose tolerance testing in adults with cystic fibrosis and risk of developing cystic fibrosis-related diabetes.

Rescue of CFTR NBD2 mutants N1303K and S1235R is influenced by the functioning of the autophagosome

  • Read more about Rescue of CFTR NBD2 mutants N1303K and S1235R is influenced by the functioning of the autophagosome

Measured fetal and neonatal exposure to Lumacaftor and Ivacaftor during pregnancy and while breastfeeding

  • Read more about Measured fetal and neonatal exposure to Lumacaftor and Ivacaftor during pregnancy and while breastfeeding

Continuous glucose monitoring abnormalities in cystic fibrosis youth correlate with pulmonary function decline.

  • Read more about Continuous glucose monitoring abnormalities in cystic fibrosis youth correlate with pulmonary function decline.

Respiratory rate in infants with cystic fibrosis throughout the first year of life and association with lung clearance index measured shortly after birth

  • Read more about Respiratory rate in infants with cystic fibrosis throughout the first year of life and association with lung clearance index measured shortly after birth

Emergence of livestock-associated MRSA isolated from cystic fibrosis patients: result of a Belgian national survey

  • Read more about Emergence of livestock-associated MRSA isolated from cystic fibrosis patients: result of a Belgian national survey

Impact of a program ensuring consistent response to acute drops in lung function in children with cystic fibrosis.

  • Read more about Impact of a program ensuring consistent response to acute drops in lung function in children with cystic fibrosis.

Interleukin-1 is associated with inflammation and structural lung disease in young children with cystic fibrosis

  • Read more about Interleukin-1 is associated with inflammation and structural lung disease in young children with cystic fibrosis

AGTR2 absence or antagonism prevents cystic fibrosis pulmonary manifestations

  • Read more about AGTR2 absence or antagonism prevents cystic fibrosis pulmonary manifestations
  • first
  • previous
  • …
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • …
  • next
  • last
Terms & Conditions Privacy policy  Accessibility Sitemap Contact 
© EUROPEAN CYSTIC FIBROSIS SOCIETY 2025. All rights reserved. Website by VidaVia (link is external)
European Cystic Fibrosis Society (ECFS)